RxDoctor Payments DataLook up a doctor →

Michele Cerra

Family · Raleigh, NCNPI 1962616268

Payments from drug & device makers

$332,475in general payments, 2019–2025

Across 634 payments — averaging $524.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$95K
  • Lilly USA, LLC$50K
  • Janssen Scientific Affairs, LLC$46K
  • Sanofi$42K
  • Amgen$38K
  • AstraZeneca$30K
  • plus $31K from 10 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson144$95,202
Lilly USA, LLC85$49,685
Janssen Scientific Affairs, LLC56$46,158
Sanofi82$41,875
Amgen(2 entities)75$38,439
AstraZeneca79$30,040
Eli Lilly36$18,251
AbbVie52$8,737
E.r. Squibb & Sons, L.L.C.5$1,602
Sobi, Inc4$1,554
Novartis9$437
Pfizer3$159
Mallinckrodt Hospital Products Inc.1$122
GSK1$107
Sanofi-aventis U.S. LLC1$81
UCB, Inc.1$27

How this compares

$332,475 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$45,191
Medicare patients
176
Services billed
1,986

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →